Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Amazon investiert Millionen in Kernenergie - so können Sie sich früh positionieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1C129 | ISIN: CA0805581091 | Ticker-Symbol: VE7
Frankfurt
23.01.25
08:01 Uhr
0,053 Euro
-0,004
-6,19 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
BELO SUN MINING CORP Chart 1 Jahr
5-Tage-Chart
BELO SUN MINING CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0890,10123.01.
GlobeNewswire (Europe)
135 Leser
Artikel bewerten:
(0)

Belo Sun Mining Corp.: Belo Sun Announces 2024 AGM Voting Results

Finanznachrichten News

TORONTO, June 11, 2024 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. ("Belo Sun" or the "Company") (TSX:BSX OTCQX:BSXGF) is pleased to provide the voting results from the Annual and Special Meeting of shareholders in accordance with the policies of the Toronto Stock Exchange.

The Company announces that the nominees listed in the management proxy circular dated May 3, 2024 (the "Circular") for the 2024 annual and special meeting of shareholders of Belo Sun (the "Meeting") were elected as directors of the Company. Shareholders at the Meeting also approved the appointment of the Company's auditors.

Detailed results of the vote for the election of directors held at the Meeting on June 11, 2024 in Toronto, Ontario are set out below.

Election of Directors

The shareholders approved the election as directors of the persons listed below, based on the following vote.

Nominee% Votes For% Votes Withheld
Mark Eaton81.28918.704
Carol Fries80.83119.169
Peter Nixon80.64519.355
Rui Botica Santos91.7198.281
Ayesha Hira84.23615.764

Shareholders voted 84.421% in favour of the approval of the appointment of the Company's auditors, with 15.579% of shareholders withholding their vote on the appointment of auditors.

Shareholders at the Meeting also approved the Company's stock option plan and all unallocated entitlements (the "Stock Option Plan"), with 78.612% in favour and 21.388% against. A total of 277,051,976 common shares were voted in connection at the Meeting, representing approximately 60.88% of the issued and outstanding common shares of the Company.

Belo Sun's board would like to express its gratitude to its shareholders for their high levels of participation and support.

About the Company

Belo Sun is a Canadian-based mining company with a portfolio of gold-focused properties in Brazil. The Company is currently focused on the development of the Volta Grande Gold Project. Belo Sun trades on the Toronto Stock Exchange under the symbol "BSX" and on the OTCQX under the symbol "BSXGF". For more information, please visit www.belosun.com or contact Investor Relations at +1 416 861-2262

Caution regarding forward-looking information:

This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the Meeting; voting results; and the election of directors. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including risks inherent in the mining industry and risks described in the public disclosure of the Company which is available under the profile of the Company on SEDAR at www.sedar.com and on the Company's website at www.belosun.com. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.